[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346005-105":59,"doc-detail-346005-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","d-serine-as-a-metabolic-immune-checkpoint-in-the-tumour-microenvironment","D-serine as a metabolic immune checkpoint in the tumour microenvironment","","D-amino acids, especially D-serine (D-ser), are detected in mammals, but their contribution to cancer immunity is not well defined. This study investigated how D-AAs shape the tumour immune microenvironment and influence clinical outcomes in gastrointestinal cancers, with a focus on D-ser. Using mouse models and gastric cancer organoid allografts, immune changes were evaluated by single-cell RNA sequencing, flow cytometry, co-culture assays, and microbiome manipulation. Plasma, urine, and stool D-AAs were quantified in multiple patient cohorts, linking elevated D-ser to disease stage, immunosuppression, and poor response to anti–PD-1 therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/d-serine-as-a-metabolic-immune-checkpoint-in-the-tumour-microenvironment/346005/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/d-serine-as-a-metabolic-immune-checkpoint-in-the-tumour-microenvironment/346005.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main question this study addresses about D-serine?","Question",{"text":112,"@type":113},"The study asks how D-amino acids, particularly D-serine, shape the tumour immune microenvironment and whether they affect responsiveness to immunotherapy in gastrointestinal cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers test the immune effects of D-serine?",{"text":117,"@type":113},"They used mechanistic experiments in mouse MC38 tumours and orthotopic gastric cancer organoid allografts, assessing immune changes with single-cell RNA sequencing, flow cytometry, macrophage–T cell co-culture assays, and microbiome manipulation.",{"name":119,"@type":110,"acceptedAnswer":120},"What clinical association did the study find for plasma D-serine levels?",{"text":121,"@type":113},"Across clinical cohorts, plasma D-serine levels were elevated in gastric cancer patients versus healthy controls and correlated with disease stage, associating with an immunosuppressive microenvironment and poor response to anti–PD-1 monotherapy in advanced gastric cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346005,1791222286,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Articles  \nD-serine as a metabolic immune checkpoint in the tumour microenvironment  \nKai Tsugaru,a,o Shohei Suzuki,a,o Kentaro Miyamoto,a,b,o Kazuhiro Murakami,c Akihiko Chida,a Chihiro Kato,a Naoto Fukasawa,a Arina Shigehara,a Mai Hasegawa,a Yusuke Yoshimatsu,a Jumpei Sasabe,d Masashi Mita,e Nick Barker,f,g Yosuke Harada,a Yasutaka Sukawa,a Toshiaki Teratani,a Nobuhiro Nakamoto,a Hirofumi Kawakubo,h Kaoru Takabayashi,i Motohiko Kato,i Naohisa Yahagi,j Taisuke Kondo,k Eri Arai,l Yuko Kitagawa,h Kenro Hirata,a Yasuo Hamamoto,a,m Takanori Kanai,a,∗ and Tomohisa Sujinon,∗∗,p  \naDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan  \nbMiyarisan Pharmaceutical Co., Ltd., Research Laboratory, Tokyo, 114-0016, Japan  \ncDivision of Epithelial Stem Cell Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan  \ndLaboratory of Electron Microscopy and Chiral Medical Biology, Keio University School of Medicine, Tokyo, 160-8582, Japan eKagami Inc., Osaka, Japan  \nfInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*Star), 138673, Singapore gDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore hDepartment of Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan  \niCenter for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, Tokyo, 160-8582, Japan  \njDivision of Research and Development for Minimally Invasive Treatment Cancer Center, Keio University School of Medicine, Tokyo, 160-8582, Japan  \nkDivision of Tumour Immunology, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, 160-8582, Japan  \nlDepartment of Pathology, Keio University School of Medicine, Tokyo, 160-8582, Japan  \nmDepartment of Medical Oncology, Institute of Science Tokyo, Bunkyo-ku, Tokyo, 113-8519, Japan  \nnDepartment of Multidimensional Analysis of Gastrointestinal Biology, The Sakaguchi Laboratory, Keio University School of Medicine, Tokyo, 160-8582, Japan  \nSummary  \nBackground D-amino acids (D-AAs), the enantiomers of proteinogenic L-amino acids, are detectable in mammals, yet their biological roles in cancer immunity remain largely unexplored. Whether specific D-AAs modulate tumour progression or influence responsiveness to immunotherapy in gastrointestinal cancer is unknown. We aimed to determine how D-AAs, particularly D-serine (D-ser), shape the tumour immune microenvironment and affect clinical outcomes in gastrointestinal cancers.  \nMethods Mechanistic studies were conducted using murine MC38 tumours and orthotopic gastric cancer (GC) organoid allografts with or without D-AAs supplementation. Immune landscape alterations were assessed using single-cell RNA sequencing of tumour-infiltrating immune cells, flow cytometry, ex vivo macrophage–T cell co-culture assays, and microbiome manipulation experiments. D-AAs concentrations in plasma, urine, and stool were quantified in healthy controls (HCs; n = 87) and patients with GC across three cohorts (Cohort 1, n = 14; Cohort 2, n = 108; Cohort 3, n = 28) . Associations between plasma D-ser levels, disease stage, immune cell infiltration, and clinical outcomes following anti–PD-1 antibody therapy were analysed.  \nFindings D-ser promoted tumour progression by suppressing CD8+ T cell immunity and enhancing SPP1-associated immunosuppressive macrophage signalling in murine model. Across all clinical cohorts, the plasma, urine, and stool levels of several D-AAs, most prominently D-ser, were significantly elevated in patients with GC compared to HCs. Plasma concentration of D-ser strongly correlated with disease stage (I–IV) . Elevated plasma D-ser is associated with an immunosuppressive tumour microenvironment and poor response to anti–PD-1 monotherapy in patients with advanced gastric cancer.  \n*Corresponding author.  \n**Corresponding author.  \nE-mail addresses: ","cbCaioCwkerYHeKA","https://ap.wps.com/l/cbCaioCwkerYHeKA","pdf",6078842,25,"English","# Summary\n## Background\n## Methods\n## Findings\n## Interpretation\n## Funding","[{\"question\":\"What is the main question this study addresses about D-serine?\",\"answer\":\"The study asks how D-amino acids, particularly D-serine, shape the tumour immune microenvironment and whether they affect responsiveness to immunotherapy in gastrointestinal cancers.\"},{\"question\":\"How did the researchers test the immune effects of D-serine?\",\"answer\":\"They used mechanistic experiments in mouse MC38 tumours and orthotopic gastric cancer organoid allografts, assessing immune changes with single-cell RNA sequencing, flow cytometry, macrophage–T cell co-culture assays, and microbiome manipulation.\"},{\"question\":\"What clinical association did the study find for plasma D-serine levels?\",\"answer\":\"Across clinical cohorts, plasma D-serine levels were elevated in gastric cancer patients versus healthy controls and correlated with disease stage, associating with an immunosuppressive microenvironment and poor response to anti–PD-1 monotherapy in advanced gastric cancer.\"}]","D-serine as a metabolic immune checkpoint in the tumour microenvironment | PDF",1790059651,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31f4b092a44c676d8313f110a852d1ce.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c12f9a98a2230027d93b8ab22af4863.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7812a64053b1b6e12c1cdfd9ea66c9de.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb3c72f73d1070d1caa05100f9fd1774.webp",980,1306]